Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 51 (RN7SKP51) is one of the numerous pseudogene variants related to the functional RNA, 7SK small nuclear RNA (RN7SK), which has a well-established role in regulating transcription elongation by RNA polymerase II via sequestration of positive transcription elongation factor b (P-TEFb)[1][2][3]. RN7SKP51 itself is annotated as a pseudogene, meaning it does not produce a functional RNA or protein product and is typically not considered an active molecular target[3]. The functional 7SK RNA, not RN7SKP51, forms the 7SK ribonucleoprotein (RNP) complex that is important for cellular transcriptional regulation[2][3]. Pseudogenes like RN7SKP51 may be transcribed but lack evidence for biological function, disease relevance, or direct pharmacological targeting[3]. There is no evidence in the literature that RN7SKP51 is implicated in disease or is therapeutically targeted, nor is it used as a biomarker or associated with clinical safety concerns. RN7SKP51 is likely annotated by sequence homology alone, reflecting a nonfunctional copy of the parent RN7SK gene. Note: If you intended to ask about the functional form, "RNA, 7SK small nuclear RNA" (RN7SK), that molecule is classified as a long non-coding RNA (lncRNA), involved in transcription regulation, immune cell differentiation, and implicated in cancer and other diseases[1][2][3]. However, "RN7SK pseudogene 51" itself should not be considered a true functional target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 51 (RN7SKP51).